The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery

por Anson, Donald S
Publicado 2004

Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair

por Koldej, Rachel M, Anson, Donald S
Publicado 2009

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA

por Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Roberts, Ainslie, Clements, Peter R, Dunning, Kylie, Byers, Sharon
Publicado 2007

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles

por Bridge, Simon H, Sharpe, Sally A, Dennis, Mike J, Dowall, Stuart D, Getty, Brian, Anson, Donald S, Skinner, Michael A, Stewart, James P, Blanchard, Tom J
Publicado 2011